Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy

A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news121874681.html">Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy</a></p> <p>A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal <i>Nature</i>.</p>